Corlux: Clinical Trials

3 trials of Corlux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Corlux: new trials by email Literature Review of Corlux trials Research Report on Corlux

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Mifepristone - Cushing's Disease, Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics42010-11-012014-03-18
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics302009-07-012014-04-02
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics502007-12-012013-08-22

Conditions studied

ACTH Syndrome, Ectopic (3)  ·  Cushing Syndrome (3)  ·  Pituitary ACTH Hypersecretion (3)  ·  Pituitary Diseases (3)  ·  Adrenal Cortex Neoplasms (2)  ·  Choristoma (2)  ·  Hirsutism (2)

Sponsors

Corcept Therapeutics (3)

Countries

United States (3)

Top investigators

Coleman Gross (1)  ·  Coleman Gross, M.D. (1)  ·  Coleman Gross, MD (1)

Results publications

PMID 25013998, PMID 26507877, PMID 22466348, PMID 23970725